Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460382
Status:
COMPLETED
Last Update Posted:
2010-09-17
First Post:
2007-04-12
Brief Title:
Clinical Trial to Assess the Efficacy of DarunavirRitonavir DRVr Etravirine ETV and Raltegravir MK-0518 in HIV Patients With Resistant Viruses
Sponsor:
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
103
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: